- ￥1818 - 4065
- MedChemExpress(MCE)
- 美国
- HY-111409
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
香烟烟雾如何加速声带纤维化？CD44-透明质酸轴是关键通路Takara 秋促来袭，提取+反转录+定量套装仅 1200 元五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
4°C, sealed storage, away from moisture and light
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
2095515-38-9
- 规格：
10 mM * 1 mL/1 mg/5 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥4065.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥1818.0 |
| 规格： | 5 mg | 产品价格： | ￥4000.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
RIP1 kinase inhibitor 1
CAS No. : 2095515-38-9
MCE 国际站：RIP1 kinase inhibitor 1
产品活性：RIP1 kinase inhibitor 1 (compound 22) 是一种高效的，口服有效的，可穿透大脑的 RIP1 激酶抑制剂 (pKi=9.04)。
研究领域：Apoptosis
作用靶点：RIP kinase
In Vitro: RIP1 kinase inhibitor 1 (compound 22) strongly suppresses necroptotic cell death and phosphorylation of MLKL(pMLKL) in human colorectal adenocarcinoma HT-29 cells (nectoptosis, IC50=2 nM; pMLKL, IC50=1.3 nM) as well as mouse L-cells NCTC 929 (nectoptosis, IC50=15 nM; pMLKL, IC50=2.7 nM).
相关产品：Bioactive Compound Library Plus | Apoptosis Compound Library | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | NF-κB Signaling Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Serine/Threonine Kinase Inhibitor Library | Necrostatin-1 | GSK-872 | Necrostatin 2 racemate | GSK2982772 | GSK583 | GSK-843 | GSK840 | GSK547 | RIPA-56 | RIP1/RIP3/MLKL activator 1 | WEHI-345 | GSK2983559 | PROTAC RIPK degrader-2 | Apostatin-1 | GSK3145095 | HS-1371 | GSK2593074A | GSK963 | PROTAC RIPK degrader-6 | RIPK3-IN-1 | Eclitasertib | ICCB-19 hydrochloride | OD36 | GSK481 | PK68 | RIPK-IN-4
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Kinase Inhibitor Profiling Using Chemoproteomics
Quantitative chemoproteomics has recently emerged as an experimental approach to determine protein interaction profiles of small molecules in a given cell line or tissue. In contrast to standard biochemical and biophysical kinase assays
Kinase Inhibitor Selectivity Profiling Using Differential Scanning Fluorimetry
and widely used approach is the direct measurement of the effect of the added ligands on its activity. A variety of enzymatic assay formats have been successfully applied for inhibitor screening of protein kinases. However, enzymatic assays require an active
generation through preclinical candidate selection. In this chapter we describe the development, validation, and implementation of an HCS assay to screen compounds from a kinase-focused small-molecule library to identify inhibitors of the p38 pathway using
技术资料暂无技术资料 索取技术资料
